Tokyo - Delayed Quote JPY
Pharma Foods International Co., Ltd. (2929.T)
908.00
+11.00
+(1.23%)
At close: April 25 at 3:30:00 PM GMT+9
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Total Revenue
62,147,000
62,147,000
68,572,000
60,185,000
46,752,000
Cost of Revenue
13,395,000
13,395,000
13,293,000
12,077,000
7,027,000
Gross Profit
48,751,000
48,751,000
55,279,000
48,108,000
39,724,000
Operating Expense
43,635,000
43,635,000
51,667,000
47,026,000
34,049,000
Operating Income
5,116,000
5,116,000
3,612,000
1,082,000
5,675,000
Net Non Operating Interest Income Expense
-61,000
-61,000
-47,000
-24,000
-9,000
Pretax Income
5,034,000
5,034,000
3,542,000
1,423,000
5,765,000
Tax Provision
1,828,000
1,828,000
462,000
1,797,000
1,924,000
Net Income Common Stockholders
3,205,000
3,205,000
3,081,000
-374,000
3,841,000
Diluted NI Available to Com Stockholders
3,205,000
3,205,000
3,081,000
-374,000
3,841,000
Basic EPS
112.71
--
106.70
-12.89
132.21
Diluted EPS
112.71
--
106.70
-12.89
132.14
Basic Average Shares
28,435.81
--
28,875.35
29,013.83
29,053.37
Diluted Average Shares
28,435.81
--
28,875.35
29,013.83
29,067.66
Total Operating Income as Reported
5,113,000
5,113,000
3,610,000
1,080,000
5,673,000
Total Expenses
57,030,000
57,030,000
64,960,000
59,103,000
41,076,000
Net Income from Continuing & Discontinued Operation
3,205,000
3,205,000
3,081,000
-374,000
3,841,000
Normalized Income
3,347,051
3,347,051
3,134,878
-495,344
3,841,666
Interest Income
1,000
1,000
1,000
2,000
3,000
Interest Expense
62,000
62,000
48,000
26,000
12,000
Net Interest Income
-61,000
-61,000
-47,000
-24,000
-9,000
EBIT
5,096,000
5,096,000
3,590,000
1,449,000
5,777,000
EBITDA
6,003,000
6,003,000
4,136,000
1,969,000
5,958,000
Reconciled Cost of Revenue
13,395,000
13,395,000
13,293,000
12,077,000
7,027,000
Reconciled Depreciation
907,000
907,000
546,000
520,000
181,000
Net Income from Continuing Operation Net Minority Interest
3,205,000
3,205,000
3,081,000
-374,000
3,841,000
Total Unusual Items Excluding Goodwill
-223,000
-223,000
-62,000
158,000
-1,000
Total Unusual Items
-223,000
-223,000
-62,000
158,000
-1,000
Normalized EBITDA
6,226,000
6,226,000
4,198,000
1,811,000
5,959,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-80,949
-80,949
-8,122
36,656
-334
7/31/2021 - 6/12/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade